Melissa Hollo: Improving Pregnancy Outcomes in Pulmonary Arterial Hypertension
Melissa Hollo, Licensed Independent Clinical Social Worker, Director of Project Management at hc1, shared a post on LinkedIn about a recent article by Li Mu et al, published in European Journal of Obstetrics and Gynecology and Reproductive Biology, adding:
“Maternal health technology is making significant strides, benefiting both mothers and their babies.
A recent study published in the European Journal of Obstetrics and Gynecology and Reproductive Biology highlights that elevated SPP1 levels may help identify pregnant women with pulmonary arterial hypertension (PAH) who are at an increased risk for serious postpartum complications.
The research is compelling, and the next step is to integrate these advancements into routine clinical care.
Solutions like hc1 Clinical IQ HerCare assist health systems in operationalizing emerging evidence by:
- Identifying patients who may benefit from additional testing
- Supporting standardized care pathways
- Enabling earlier intervention
Earlier identification paves the way for better proactive care, steering maternal healthcare in a positive direction.
Learn how we’re supporting earlier maternal risk detection.”
Title: SPP1 improves early risk assessment of postpartum adverse events in pulmonary arterial hypertension complicated with pregnancy
Authors: Li Mu, Hui Yuan, Jun Zhang, Junyi Wu, Haofeng Zhang, Jiashu Yang
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke